A citation-based method for searching scientific literature

Ophira Ginsburg, Patricia Ashton-Prolla, Anna Cantor, Daniela Mariosa, Paul Brennan. Nat Rev Clin Oncol 2021
Times Cited: 3







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Clonal evolution in cancer.
Mel Greaves, Carlo C Maley. Nature 2012
33


Limits to Personalized Cancer Medicine.
Ian F Tannock, John A Hickman. N Engl J Med 2016
198
33

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial.
Tony S K Mok, Yi-Long Wu, Iveta Kudaba, Dariusz M Kowalski, Byoung Chul Cho, Hande Z Turna, Gilberto Castro, Vichien Srimuninnimit, Konstantin K Laktionov, Igor Bondarenko,[...]. Lancet 2019
893
33

Tumour heterogeneity and resistance to cancer therapies.
Ibiayi Dagogo-Jack, Alice T Shaw. Nat Rev Clin Oncol 2018
692
33

A Big Bang model of human colorectal tumor growth.
Andrea Sottoriva, Haeyoun Kang, Zhicheng Ma, Trevor A Graham, Matthew P Salomon, Junsong Zhao, Paul Marjoram, Kimberly Siegmund, Michael F Press, Darryl Shibata,[...]. Nat Genet 2015
508
33

The National Lung Matrix Trial of personalized therapy in lung cancer.
Gary Middleton, Peter Fletcher, Sanjay Popat, Joshua Savage, Yvonne Summers, Alastair Greystoke, David Gilligan, Judith Cave, Noelle O'Rourke, Alison Brewster,[...]. Nature 2020
25
33

Tracking the Evolution of Non-Small-Cell Lung Cancer.
Mariam Jamal-Hanjani, Gareth A Wilson, Nicholas McGranahan, Nicolai J Birkbak, Thomas B K Watkins, Selvaraju Veeriah, Seema Shafi, Diana H Johnson, Richard Mitter, Rachel Rosenthal,[...]. N Engl J Med 2017
913
33

Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.
Marco Gerlinger, Andrew J Rowan, Stuart Horswell, M Math, James Larkin, David Endesfelder, Eva Gronroos, Pierre Martinez, Nicholas Matthews, Aengus Stewart,[...]. N Engl J Med 2012
33

The high price of anticancer drugs: origins, implications, barriers, solutions.
Vinay Prasad, Kevin De Jesús, Sham Mailankody. Nat Rev Clin Oncol 2017
140
33

Top 10 Challenges in Cancer Immunotherapy.
Priti S Hegde, Daniel S Chen. Immunity 2020
213
33

Massive genomic rearrangement acquired in a single catastrophic event during cancer development.
Philip J Stephens, Chris D Greenman, Beiyuan Fu, Fengtang Yang, Graham R Bignell, Laura J Mudie, Erin D Pleasance, King Wai Lau, David Beare, Lucy A Stebbings,[...]. Cell 2011
33

Adaptive mutability of colorectal cancers in response to targeted therapies.
Mariangela Russo, Giovanni Crisafulli, Alberto Sogari, Nicole M Reilly, Sabrina Arena, Simona Lamba, Alice Bartolini, Vito Amodio, Alessandro Magrì, Luca Novara,[...]. Science 2019
92
33

The evidence landscape in precision medicine.
Spencer Phillips Hey, Cory V Gerlach, Garrett Dunlap, Vinay Prasad, Aaron S Kesselheim. Sci Transl Med 2020
8
33

Smart drugs: tyrosine kinase inhibitors in cancer therapy.
Laura K Shawver, Dennis Slamon, Axel Ullrich. Cancer Cell 2002
359
33

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia.
Andreas Hochhaus, Richard A Larson, François Guilhot, Jerald P Radich, Susan Branford, Timothy P Hughes, Michele Baccarani, Michael W Deininger, Francisco Cervantes, Satoko Fujihara,[...]. N Engl J Med 2017
434
33



The price we pay for progress: a meta-analysis of harms of newly approved anticancer drugs.
Saroj Niraula, Bostjan Seruga, Alberto Ocana, Tiffany Shao, Robyn Goldstein, Ian F Tannock, Eitan Amir. J Clin Oncol 2012
109
33

Liquid biopsy and minimal residual disease - latest advances and implications for cure.
Klaus Pantel, Catherine Alix-Panabières. Nat Rev Clin Oncol 2019
242
33

Liquid biopsies come of age: towards implementation of circulating tumour DNA.
Jonathan C M Wan, Charles Massie, Javier Garcia-Corbacho, Florent Mouliere, James D Brenton, Carlos Caldas, Simon Pacey, Richard Baird, Nitzan Rosenfeld. Nat Rev Cancer 2017
865
33

Tumor Evolution as a Therapeutic Target.
Nabil Amirouchene-Angelozzi, Charles Swanton, Alberto Bardelli. Cancer Discov 2017
86
33

Hans Christian Andersen and the Value of New Cancer Treatments.
Richard L Schilsky, Lowell E Schnipper. J Natl Cancer Inst 2018
4
33


Making the Case for Investment in Rural Cancer Control: An Analysis of Rural Cancer Incidence, Mortality, and Funding Trends.
Kelly D Blake, Jennifer L Moss, Anna Gaysynsky, Shobha Srinivasan, Robert T Croyle. Cancer Epidemiol Biomarkers Prev 2017
102
33

Cancer risk and risk communication in urban, lower-income neighborhoods.
Kimberly M Kelly, Amy K Ferketich, Amy C Sturm, Kyle Porter, Kevin Sweet, Kathleen Kemp, Patricia Schwirian, Judith A Westman. Prev Med 2009
13
33

Using Health Chatbots for Behavior Change: A Mapping Study.
Juanan Pereira, Óscar Díaz. J Med Syst 2019
20
33

Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.
Matthew B Yurgelun, Matthew H Kulke, Charles S Fuchs, Brian A Allen, Hajime Uno, Jason L Hornick, Chinedu I Ukaegbu, Lauren K Brais, Philip G McNamara, Robert J Mayer,[...]. J Clin Oncol 2017
165
33

Determining Onset for Familial Breast and Colorectal Cancer from Family History Comments in the Electronic Health Record.
Danielle L Mowery, Kensaku Kawamoto, Rick Bradshaw, Wendy Kohlmann, Joshua D Schiffman, Charlene Weir, Damian Borbolla, Wendy W Chapman, Guilherme Del Fiol. AMIA Jt Summits Transl Sci Proc 2019
9
33



Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
Matthew B Yurgelun, Brian Allen, Rajesh R Kaldate, Karla R Bowles, Thaddeus Judkins, Praveen Kaushik, Benjamin B Roa, Richard J Wenstrup, Anne-Renee Hartman, Sapna Syngal. Gastroenterology 2015
142
33

Primary care providers' responses to patient-generated family history.
Melissa Fuller, Melanie Myers, Thomas Webb, Meredith Tabangin, Cynthia Prows. J Genet Couns 2010
21
33

Genetic counselor workflow study: The times are they a-changin'?
Courtney A Attard, Erin P Carmany, Angela M Trepanier. J Genet Couns 2019
14
33

Testing for germline mutations in sporadic pheochromocytoma/paraganglioma: a systematic review.
Juan P Brito, Noor Asi, Irina Bancos, Michael R Gionfriddo, Claudia L Zeballos-Palacios, Aaron L Leppin, Chaitanya Undavalli, Zhen Wang, Juan P Domecq, Gabriela Prustsky,[...]. Clin Endocrinol (Oxf) 2015
47
33

Genetic counseling among minority populations in the era of precision medicine.
Chanita H Halbert, Barbara W Harrison. Am J Med Genet C Semin Med Genet 2018
10
33

Family history-taking in community family practice: implications for genetic screening.
L S Acheson, G L Wiesner, S J Zyzanski, M A Goodwin, K C Stange. Genet Med 2000
174
33

Validation of a decision regret scale.
Jamie C Brehaut, Annette M O'Connor, Timothy J Wood, Thomas F Hack, Laura Siminoff, Elisa Gordon, Deb Feldman-Stewart. Med Decis Making 2003
588
33

Acceptability of artificial intelligence (AI)-led chatbot services in healthcare: A mixed-methods study.
Tom Nadarzynski, Oliver Miles, Aimee Cowie, Damien Ridge. Digit Health 2019
34
33

Access to Genetic Counselors in the Southern United States.
Catalina Villegas, Susanne B Haga. J Pers Med 2019
11
33

Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients.
Heidi S Lumish, Hallie Steinfeld, Carrie Koval, Donna Russo, Elana Levinson, Julia Wynn, James Duong, Wendy K Chung. J Genet Couns 2017
61
33

Analysis of Advantages, Limitations, and Barriers of Genetic Counseling Service Delivery Models.
Stephanie A Cohen, Rachelle C Huziak, Shanna Gustafson, Robin E Grubs. J Genet Couns 2016
33
33

Behavioral health outcomes associated with religious faith and media exposure about human genetics.
Roxanne Parrott, Kami Silk, Janice Raup Krieger, Tina Harris, Celeste Condit. Health Commun 2004
19
33

Rural-Urban Differences in Cancer Incidence and Trends in the United States.
Whitney E Zahnd, Aimee S James, Wiley D Jenkins, Sonya R Izadi, Amanda J Fogleman, David E Steward, Graham A Colditz, Laurent Brard. Cancer Epidemiol Biomarkers Prev 2018
101
33

Next-Generation Service Delivery: A Scoping Review of Patient Outcomes Associated with Alternative Models of Genetic Counseling and Genetic Testing for Hereditary Cancer.
Jeanna M McCuaig, Susan Randall Armel, Melanie Care, Alexandra Volenik, Raymond H Kim, Kelly A Metcalfe. Cancers (Basel) 2018
29
33

Gene panel testing for inherited cancer risk.
Michael J Hall, Andrea D Forman, Robert Pilarski, Georgia Wiesner, Veda N Giri. J Natl Compr Canc Netw 2014
78
33

Trust and sources of health information: the impact of the Internet and its implications for health care providers: findings from the first Health Information National Trends Survey.
Bradford W Hesse, David E Nelson, Gary L Kreps, Robert T Croyle, Neeraj K Arora, Barbara K Rimer, Kasisomayajula Viswanath. Arch Intern Med 2005
778
33





Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.